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Protein kinase C (PKC)-θ is a serine/threonine kinase belonging to the calcium-independent
novel PKC subfamily; its expression is restricted to certain tissues and cell types, includ-
ing T cells. The signals delivered from T cell receptor (TCR) and CD28 costimulatory
molecules trigger PKC-θ catalytic activation and membrane translocation to the immuno-
logical synapse, leading to activation of NF-κB, AP-1, and NF-AT.These transcription factors
are important forT cell survival, activation, and differentiation. Phosphorylation of PKC-θ at
multiple Ser/Thr/Tyr residues is induced inT cells duringTCR signaling. Some phosphoryla-
tion sites play critical roles in the regulation of PKC-θ function and downstream signaling.
The regulation mechanisms for PKC-θ phosphorylation sites are now being revealed. In
this review, we discuss the current understanding of the regulation of PKC-θ function by
phosphorylation duringTCR signaling.
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INTRODUCTION
Protein kinase C (PKC)-θ was originally cloned in 1993 as a novel
member of the PKC gene family (Baier et al., 1993; Chang et al.,
1993). Because PKC-θ is highly expressed inT cells, immunologists
have examined the roles of PKC-θ in T cell activation and immune
regulation. Nearly 20 years after its discovery, numerous studies
using cell lines and genetic animalmodels demonstrate that PKC-θ
plays essential roles in controlling peripheral T cell activation;
preventing T cell anergy; regulating the development of regula-
tory T cells, T helper (TH)2, and TH17 cells; and modulating
autoimmune pathogenesis (Marsland and Kopf, 2008; Zanin-
Zhorov et al., 2011). The signals triggered by T cell receptor
(TCR) and CD28 costimulatory molecules induce membrane
translocation and kinase activation of PKC-θ, leading to subse-
quent activation of NF-κB and AP-1 (Baier-Bitterlich et al., 1996;
Coudronniere et al., 2000; Sun et al., 2000; Bi et al., 2001). These
transcription factors induce IL-2 expression and regulate T cell
activation and functions. The regulatory mechanisms of the acti-
vation and functions of PKC-θ in T cells have been unraveled.
Post-translational regulation of PKC-θ by phosphorylation plays
important roles in regulating PKC-θ kinase activity andmembrane
translocation, both of which are essential for PKC-θ function
in T cells. Here, we focus our discussion on the function and
regulation of critical phosphorylation sites of PKC-θ in T cell
activation. Identiﬁcation of the important regulators of PKC-θ
phosphorylation may provide novel therapeutic drug targets for
autoimmunity.
STRUCTURE BASIS FOR PKC-θ ACTIVATION
Human PKC-θ is composed of 706 amino acids. The basic struc-
ture of PKC-θ is shown in Figure 1. Like other PKC family
members, PKC-θ consists of an N-terminal regulatory region
(amino acids 1–378) and a C-terminal catalytic region (amino
acids 379–706; Baier et al., 1993; Chang et al., 1993). The reg-
ulatory region displays the domain structure typical of PKC
isoforms. The C2-like domain sequence is similar to the Ca2+-
binding C2 domain sequences of other PKCs; however, it does
not bind to Ca2+. The C2-like domain of PKC-θ contains a
phosphorylated Y90 residue, which may mediate the interac-
tion with an SH2 domain-containing protein, as seen in PKC-δ
(Benes et al., 2005). In addition, the C2-like domain of PKC-
θ may interact with a receptor for activated C kinase (RACK),
which may regulate membrane translocation of PKC-θ (Schecht-
man andMochly-Rosen,2001). The interaction of a speciﬁcRACK
with PKC-θ has not been reported; however, a PKC-δ/θ selec-
tive peptide blocking an RACK-binding site on PKC-δ/θ inhibits
PKC-θ function (Nagy et al., 2009). Two tandem cysteine-rich
C1 domains bind to diacylglycerol; the C1b domain has much
higher afﬁnity for diacylglycerol than the C1a domain (Melowic
et al., 2007). A pseudosubstrate sequence (RRGAIKQA) within the
C1a domain of PKC-θ binds to the substrate-binding region in
the catalytic domain, inhibiting the PKC-θ kinase activity in the
absence of allosteric effectors. C1 domains are ﬂanked by two
variable, or hinge, regions (V1 and V3). A recent study shows that
the V3 domain is involved in the indirect association of PKC-θ
with CD28, leading to PKC-θ membrane translocation into the
immunological synapse; the interaction of lymphocyte-speciﬁc
protein tyrosine kinase (LCK) with a proline-rich motif-like
sequence in the V3 domain may be important for this action
(Kong et al., 2011).
The crystal structure of the PKC-θ catalytic domain has been
solved (Xu et al., 2004). The three-dimensional structure of PKC-
θ is shown in Figure 2. The conserved core of the structure
includes an N-terminal lobe and a C-terminal lobe, connected
by a hinge linker sequence (Xu et al., 2004). The interface of the
two lobes constitutes the active site cleft, which is responsible for
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FIGURE 1 | Structural domains and phosphorylation sites of PKC-θ.
One-way arrow indicates the phosphorylation of the indicated site by a
kinase. Two-way arrow indicates an interaction. PS, pseudosubstrate
sequence; PR, proline-rich motif.
FIGURE 2 |Three-dimensional structure of the kinase domain of PKC-θ.
ATP binds at a cleft between the N-lobe (top) and C-lobe (bottom). Key
structural elements are highlighted: the glycine-rich loop (cyan), the αC helix
(purple), the activation loop (red), the turn motif (orange), and the
hydrophobic motif (yellow). Phosphorylation sites and ATP are shown as
sticks in blue and yellow-orange, respectively.
the substrate binding and phosphate delivery (Xu et al., 2004).
The key and conserved structural elements in the PKC-θ catalytic
domain include a glycine-rich loop (GXGXXG) (involved in ATP
binding and catalysis), an αC helix (participating in the substrate
binding and catalysis), the activation loop bearing the essential
phospho-threonine-538 (T538; critical for kinase activation), the
hydrophobic motif containing phospho-serine 695 (S695), and
the turn motif containing conserved phospho-serine 676 (S676)
and phospho-serine 685 (S685) (Xu et al., 2004).
Similar to other protein kinases, PKC-θ displays two main
conformational states: “open/active” and “closed/inactive” (Xu
et al., 2004; Seco et al., 2012). In the inactive state, the pseudo-
substrate sequence in the N-terminal regulatory region of PKC-
θ forms intramolecular interaction with the substrate-binding
region in the catalytic domain (House and Kemp, 1987). This
prevents the catalytic domain from being accessible to substrates
(House and Kemp, 1987). The allosteric change of PKC-θ from
“closed” to “open” state involves two important mechanisms:
diacylglycerol binding to the C1 domains and T538 phospho-
rylation at the activation loop (Seco et al., 2012). The signal
transduction initiated from TCR/CD28 costimulation induces the
generation of second messenger diacylglycerol, which binds to
C1 domains, resulting in the exposure of the activation loop of
PKC-θ (Melowic et al., 2007). The activation loop of PKC-θ is
then accessible to phosphorylation by germinal center kinase-like
kinase (GLK, also named MAP4K3) and subsequent catalytic acti-
vation (Chuang et al., 2011). Phorbol esters such as phorbol-12,
13-dibutyrate (PDBu) and phorbol myristate acetate (PMA) are
potent non-physiological PKC-θ agonists that mimic the action
of diacylglycerol and are widely used to induce PKC-θ activation
(Ron and Kazanietz, 1999). Six phosphorylation sites have been
identiﬁed on PKC-θ: Y90, T219, T538, S676, S685, and S695.
These phosphorylation sites play distinct roles in the regulation of
PKC-θ kinase activity or membrane translocation, which will be
discussed below.
FUNCTION AND REGULATION OF PKC-θ
PHOSPHORYLATION SITES
PKC-θ Y90 PHOSPHORYLATION
Identiﬁcation and regulation of PKC-θ Y90 phosphorylation
PKC-θ is tyrosine phosphorylated in Jurkat T cells and primary
T cells upon anti-CD3 with or without anti-CD28 costimula-
tion (Liu et al., 2000; Bi et al., 2001). Coexpression with LCK,
but not other tyrosine kinases including FYN, ZAP-70, SYK, or
ITK, induces tyrosine phosphorylation of PKC-θ in COS-1 cells
(Liu et al., 2000). Furthermore, tyrosine phosphorylation of PKC-
θ is undetectable in LCK-deﬁcient Jurkat T cells upon anti-CD3
stimulation (Liu et al., 2000). Additionally, LCK is constitutively
and directly associated with PKC-θ in the transfected HEK293T
cells and Jurkat T cells, and PKC-θ can be directly phosphory-
lated by LCK in vitro and in vivo (Liu et al., 2000). To identify
the LCK-induced tyrosine phosphorylation site of PKC-θ, a series
of PKC-θ-derived short peptides containing individual tyrosine
residues are used as substrates for LCK in in vitro kinase assays
(Liu et al., 2000). The peptide containing Y90, but not other tyro-
sine residues, is signiﬁcantly phosphorylated by LCK in vitro (Liu
et al., 2000). Furthermore, substitution of Y90 with phenylalanine
abolishes LCK-induced PKC-θ tyrosine phosphorylation in trans-
fected COS-1 cells and anti-CD3-stimulated Jurkat T cells (Liu
et al., 2000). These data suggest that LCK directly phosphorylates
PKC-θ at Y90. However, in vivo Y90 phosphorylation of PKC-
θ during TCR signaling remains to be further demonstrated by
immunoblotting using a phospho-speciﬁc antibody or conﬁrmed
by mass spectrometry.
Function of PKC-θ Y90 phosphorylation
Y90 phosphorylation of PKC-θ positively regulates NF-AT and
NF-κB activation in T cells. The catalytically active PKC-θ A148E
mutant induces NF-AT and NF-κB activation in Jurkat T cells,
whereas the Y90F mutation of PKC-θ A148E mutant greatly
reduces NF-AT and NF-κB activation (Liu et al., 2000; Bi et al.,
2001). This suggests that Y90 phosphorylation regulates PKC-θ
function, leading to downstream NF-AT and NF-κB activation.
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The evidence of LCK-induced Y90 phosphorylation and mem-
brane translocation of PKC-θ suggests that Y90 phosphorylation
may regulate the membrane translocation of PKC-θ (Liu et al.,
2000; Bi et al., 2001). However, other studies suggest that LCK
regulates membrane translocation via mediating the formation
of PKC-θ/LCK/CD28 tri-partite interaction (Tavano et al., 2004;
Hoﬁnger and Sticht, 2005; Kong et al., 2011). In these studies, the
SH3 domain of LCK interacts with the proline-richmotif in theV3
domain of PKC-θ, whereas the SH2 domain of LCK is bound to the
phosphorylated Y207 of the CD28 cytoplasmic tail (Tavano et al.,
2004; Hoﬁnger and Sticht, 2005; Kong et al., 2011). PKC-θ muta-
tions at the V3 proline-rich motif suppress membrane transloca-
tion of PKC-θ to the immunological synapse and also attenuate
T cell activation upon anti-CD3/CD28 costimulation (Kong et al.,
2011). It is unknown whether Y90 phosphorylation of PKC-θ is
involved in the regulation of PKC-θ/LCK/CD28 tri-partite interac-
tion. The role of Y90 phosphorylation in the regulation of PKC-θ
membrane translocation needs to be demonstrated by more direct
evidence, such as a study of membrane translocation of PKC-θ
Y90F mutant in T cells during TCR signaling. In addition, whether
Y90 phosphorylation regulates PKC-θ catalytic activity remains
unknown.
PKC-θ T219 PHOSPHORYLATION
Identiﬁcation and regulation of PKC-θ T219 phosphorylation
T219 was originally identiﬁed as a major phosphorylation site
of PKC-θ by phosphopeptide mapping (Thuille et al., 2005). The
PKC-θ protein used for the phosphopeptide mapping is from
puriﬁed baculovirus-expressed recombinant PKC-θ after in vitro
kinase assays in the absence of exogenous substrates, suggest-
ing that T219 is an autophosphorylation site of PKC-θ (Thuille
et al., 2005). T219 phosphorylation of recombinant PKC-θ is fur-
ther demonstrated by immunoblotting using a phospho-speciﬁc
antibody, which does not recognize PKC-θ mutants with the
T219 substitution with either alanine or glutamic acid (Thuille
et al., 2005). In Jurkat T cells or primary T cells, PKC-θ T219
phosphorylation is induced by the phorbol ester PDBu, anti-
CD3 alone, anti-CD3 plus anti-CD28, or vanadate (a tyrosine
phosphatase inhibitor) (Thuille et al., 2005). The mechanism
that induces T219 phosphorylation in TCR signaling remains
unknown. However, T219 phosphorylation of PKC-θ is unde-
tectable in the kinase-dead PKC-θ K409R mutant in Jurkat T cells
upon cellular stimulation, suggesting that T219 is an inducible
autophosphorylation site of PKC-θ during T cell activation
(Thuille et al., 2005).
Function of PKC-θ T219 phosphorylation
T219 phosphorylation of PKC-θ is important for PKC-θ-mediated
T cell activation upon TCR stimulation (Thuille et al., 2005). PKC-
θ T219A mutant abrogates TCR-induced activation of NF-κB
and NF-AT as well as subsequent IL-2 promoter transactivation
in Jurkat T cells (Thuille et al., 2005). Interestingly, although
loss of T219 phosphorylation impairs PKC-θ-mediated cellular
function, PKC-θ T219A mutant is catalytically intact in vitro
(Thuille et al., 2005). Similarly, PKC-θ T219A mutant shows
slightly increased lipid-binding activity with PDBu (Thuille et al.,
2005). These data suggest that T219 phosphorylation regulates
PKC-θ-mediated downstream signaling in T cells through a mech-
anism independent of PKC-θ kinase activity (Thuille et al., 2005).
In contrast, PKC-θT219Amutant is unable to translocate into lipid
rafts or the immunological synapse in Jurkat T cells in response
to TCR stimulation or in the presence of antigen-presenting
cells; forced membrane translocation of PKC-θ T219A mutant
by adding a membrane-targeting sequence reconstitutes TCR-
induced NF-κB activation in Jurkat T cells (Thuille et al., 2005).
Taken together, these data suggest that T219 phosphorylation
is required for properly localizing PKC-θ to the cell mem-
brane, allowing PKC-θ to activate downstream effectors in TCR
signaling.
PHOSPHORYLATION OF PKC-θ AT T538 IN THE ACTIVATION MOTIF
Identiﬁcation of PKC-θ autophosphorylation sites at the
catalytic domain
Multiple sequence alignment of the catalytic domains of PKC
isoforms shows the conserved serine/threonine phosphorylation
residues in the activation loop, turn motif, and hydropho-
bic motif (Liu et al., 2002; Xu et al., 2004). Phosphorylations
of T538 at the activation loop, S676 at the turn motif, and
S695 at the hydrophobic motif of PKC-θ have been demon-
strated using phospho-speciﬁc anti-sera and further conﬁrmed
by mass spectrometry (Liu et al., 2002; Czerwinski et al., 2005).
Phosphorylation of S685 at the turn motif has been demon-
strated only by mass spectrometry (Czerwinski et al., 2005). T538,
S676, and S695 are constitutively phosphorylated on recombinant
PKC-θ isolated from baculovirus, E. coli, or HEK293T expres-
sion systems (Liu et al., 2002; Czerwinski et al., 2005; Thuille
et al., 2005). The PKC-θ kinase-dead mutant (K409W) abolishes
phosphorylation of these three sites in the recombinant PKC-
θ, suggesting that they are regulated by autophosphorylation
(Liu et al., 2002; Czerwinski et al., 2005). Autophosphoryla-
tion can be induced in a cis or trans manner. An intrapep-
tide reaction in a mixed micelle system shows that PKC-θ
autophosphorylation is regulated by intrapeptide phosphoryla-
tion (Newton and Koshland, 1987). Catalytic-competent PKC-θ
is unable to phosphorylate PKC-θ-derived peptides containing the
individual autophosphorylation sites, further supporting that an
intramolecular interaction is required for autophosphorylation
on these sites (Thuille et al., 2005). Crystal structure of PKC-θ
shows that the activation loop, the turn motif, and hydropho-
bic motif lie close to the active cleft (Xu et al., 2004), supporting
that T538, S676, and S695 are autophosphorylated in cis. So far,
the function and regulation of T538 phosphorylation are the best
known and the most intensively studied, whereas the functions
and regulations of other three phosphorylation sites in T cells are
less clear.
Function of PKC-θ T538 phosphorylation
The activation loop is a short critical polypeptide that lies out-
side the active site cleft of the kinase domain (Nolen et al., 2004).
The activation loop contributes to binding surfaces for substrates
and co-factors (Nolen et al., 2004). The crystal structure of PKC-θ
shows that the phosphate of T538 in the activation loop forms
hydrogen-bonding interaction with the αC helix, which helps to
stabilize the correct orientation of the αC helix and to maintain
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active conformation of this kinase (Xu et al., 2004). Loss of T538
phosphorylation in PKC-θ T538A mutant abolishes PKC-θ kinase
activity, indicating that T538 is a critical activation site regulating
PKC-θ kinase activity (Liu et al., 2002; Czerwinski et al., 2005).
Therefore, T538 phosphorylation is widely used as a surrogate
marker for PKC-θ kinase activation. T538 phosphorylation does
not seem to regulate PKC-θ membrane translocation, because
PKC-θ T538A mutant still translocates into lipid rafts in T cells
upon anti-CD3/CD28 stimulation (Thuille et al., 2005). Consis-
tent with loss of kinase activation of PKC-θ T538A mutant, the
downstreamNF-κBandNF-ATactivations are abrogated inPKC-θ
T538A-transfected Jurkat T cells upon anti-CD3/CD28 costimu-
lation (Liu et al., 2002; Thuille et al., 2005), indicating that T538
is a critical phosphorylation site required for PKC-θ function and
T cell activation.
Inducible PKC-θ T538 phosphorylation in T cell signaling
While it is undoubtedly true that T538 is constitutively autophos-
phorylated in the recombinant PKC-θ proteins isolated from
different expression systems (Liu et al., 2002; Xu et al., 2004; Czer-
winski et al., 2005; Thuille et al., 2005), whether PKC-θ T538
phosphorylation is constitutive or inducible during T cell activa-
tion has been controversial. A constitutive T538 phosphorylation
of endogenous PKC-θ has been detected in Jurkat and primary T
cells using the phospho-speciﬁc antibodies from different sources,
and T538 phosphorylation is not further enhanced by TCR or
PMA stimulation (Freeley et al., 2005; Thuille et al., 2005; Gruber
et al., 2006). The observation of constitutive PKC-θ T538 phos-
phorylation in T cells reported in some studies maybe due to high
basal PKC-θ activity; for example, Jurkat T cells can be easily
stimulated with serum (Lee et al., 2006). Earlier studies of PKC-θ
phosphorylation in T cells used an electrophoretic mobility shift
of PKC-θ in T cells upon anti-CD3/CD28 or PMA/ionomycin
stimulation; these studies show that PKC-θ migrates more slowly
in activated T cells than in unstimulated T cells (Thebault and
Ochoa-Garay, 2004; Puente et al., 2005). Although the phospho-
rylation of PKC-θ at T538 is not directly examined in these studies
due to the lack of use of anti-phospho-PKC-θ (T538) antibody,
PKC-θ T538A mutation abolishes the mobility shift of PKC-θ
induced by PMA (Thebault and Ochoa-Garay, 2004; Puente et al.,
2005), suggesting that T538 phosphorylation is induced by T
cell signaling. Using the phospho-speciﬁc PKC-θ T538 antibodies
from different sources, several groups show that T538 phospho-
rylation is induced during T cell activation upon anti-CD3 or
interferon stimulation (Srivastava et al., 2004; Lee et al., 2005; Liu
and Lai, 2005; Park et al., 2009; Chuang et al., 2011). The inducible
T538 phosphorylation of PKC-θ is consistent with the inducible
PKC-θ kinase activation in T cells upon TCR stimulation (Monks
et al., 1997; Coudronniere et al., 2000; Puente et al., 2005). Fur-
thermore, our group has identiﬁed GLK as the direct upstream
kinase that phosphorylates PKC-θ T538 upon TCR stimulation
(Chuang et al., 2011). Therefore, PKC-θ-dependent downstream
signaling such as IKK-NF-κB activation may need to be examined
as controls for the basal PKC-θ activity in unstimulated T cells
(Lee et al., 2005, 2006). Taken together, PKC-θ T538 phosphory-
lation and its kinase activation are induced in T cells upon TCR
stimulation.
Regulation of PKC-θ T538 phosphorylation and activation
by GLK in TCR signaling
The kinase that directly phosphorylates PKC-θ was a mystery
before the discovery of the role of GLK in TCR signaling. Initially,
3-phosphoinositide-dependent kinase-1 (PDK1) was proposed to
be the kinase directly phosphorylating PKC-θ based on the fol-
lowing evidence: (i) PKC-θ T538 phosphorylation is impaired
in PDK1-knockdown Jurkat T cells and PDK1-deﬁcient primary
T cells upon anti-CD3/CD28 stimulation (Lee et al., 2005; Park
et al., 2009); (ii) PDK1 is associated with PKC-θ in the lipid rafts
of T cells during anti-CD3/CD28 stimulation (Lee et al., 2005);
(iii) PDK1 directly phosphorylates the conserved phosphorylation
site at the activation loopof the other PKC isoforms (LeGood et al.,
1998; Balendran et al., 2000). However, several observations indi-
cate that PDK1 may not be the direct upstream kinase for PKC-θ:
(i) anti-CD3 stimulation alone without anti-CD28 costimulation
is sufﬁcient to induce phosphorylation and activation of PKC-θ
but not PDK1 (Liu and Lai, 2005; Park et al., 2009); (ii) PDK1-
deﬁcient T cells still show residual PKC-θ T538 phosphorylation
(Park et al., 2009); and (iii) there is lack of in vitro phosphory-
lation of PKC-θ by PDK1 to demonstrate that PKC-θ is a direct
substrate of PDK1. A recent study suggests that AMP-activated
protein kinase (AMPK) may be involved in PKC-θ T538 phos-
phorylation in Jurkat T cells upon PMA/ionomycin stimulation
(Lee et al., 2012). In addition, APMK is also implicated in phos-
phorylation of PKC-ζ on its activation loop in the cells under the
hypoxia (Gusarova et al., 2009). However, there is no direct evi-
dence that AMPK directly phosphorylates PKC-θ at T538 in TCR
signaling (Lee et al., 2012).
GLK is a Ste20-like serine/threonine kinase that activates the
JNK pathway in response to stress stimulation (Diener et al.,
1997). Our recent study of the GLK function in T cells revealed
an important role of GLK in controlling TCR signaling, T cell
activation, immune responses, and autoimmunity via activating
PKC-θ (Chuang et al., 2011). GLK-deﬁcient T cells show abolished
phosphorylationof PKC-θT538 and IKK,aswell as reduced activa-
tion of NF-κB, upon anti-CD3 stimulation; this effect is unlikely
mediated by PDK1 because PDK1 is not activated by anti-CD3
stimulation alone (Park et al., 2009; Chuang et al., 2011). Fur-
thermore, PDK1 activation is unaffected in GLK-deﬁcient T cell
upon anti-CD3/CD28 costimulation, even though phosphoryla-
tions of PKC-θ and IKK are abolished in these cells (Chuang et al.,
2011). These data indicate that GLK activates PKC-θ independent
or downstream of PDK1. GLK is inducibly and directly associ-
ated with PKC-θ in T cells upon anti-CD3 stimulation (Chuang
et al., 2011). GLK directly phosphorylates PKC-θ at T538 but not
at S695 or S676 residue in vitro (Chuang et al., 2011). These data
unequivocally demonstrate that GLK is the kinase that directly
phosphorylates and activates PKC-θ during TCR signaling. Our
unpublished data show that PKC-θ is unable to translocate to
cell membrane in GLK-deﬁcient T cells upon anti-CD3 stim-
ulation. This effect is not likely mediated by a loss of PKC-θ
T538 phosphorylation in GLK-deﬁcient T cells, because T538A
mutation does not affect PKC-θ membrane translocation (Thuille
et al., 2005). How GLK regulates PKC-θ membrane transloca-
tion remains unknown. One potential mechanism is that GLK
may directly or indirectly induce another phosphorylation site
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(e.g., T219 or a novel S/T residue) that regulates PKC-θmembrane
translocation. Further characterization of GLK-mediated PKC-
θ phosphorylation may reveal a novel mechanism that regulates
PKC-θ membrane translocation.
PHOSPHORYLATION OF PKC-θ AT S676 AND S685
IN THE TURN MOTIF
S676 is constitutively autophosphorylated in the turn motif of
recombinant PKC-θ isolated from HEK293T cells and E. coli
expression system (Liu et al., 2002; Czerwinski et al., 2005). Basal
S676 phosphorylation of PKC-θ has also been observed in Jurkat
T cells, CTL clone AB.1 cells, and primary CD4+ T cells (Freeley
et al., 2005; Puente et al., 2005; Lee et al., 2010). The basal level
of PKC-θ S676 phosphorylation is moderately increased in mouse
primary CD4+ T cells upon anti-CD3/CD28 costimulation (Lee
et al., 2010). However, some controversy remains about the effects
of S676 phosphorylation on the PKC-θ kinase activity and down-
stream NF-κB activation (Liu et al., 2002; Czerwinski et al., 2005;
Thuille et al., 2005). PKC-θ S676A mutant isolated from Jurkat
T cells or E. coli expression system retains only 30–40% in vitro
kinase activity compared to WT (Czerwinski et al., 2005; Thuille
et al., 2005); furthermore, PKC-θ S676A mutant dramatically sup-
presses NF-κB activity in Jurkat T cells stimulated by phorbol
ester or anti-CD3 (Thuille et al., 2005). In contrast, PKC-θ S676A
mutant isolated from HEK293T cells displays intact kinase activ-
ity and does not affect TCR-induced NF-κB activity in Jurkat T
cells (Liu et al., 2002). These different results could be due to using
experimental systems or conditions. It has been observed in PKC-
βII that a single mutation of a conserved serine/threonine residue
in the turn motif does not affect PKC-βII function due to com-
pensatory phosphorylation at the neighboring residues (Edwards
et al., 1999). In a similar note, combinational mutations of S676
and other neighboring serine residues (S662 and S685) in the
turn motif of PKC-θ result in a greater loss of its kinase activity
(Liu et al., 2002).
Mass spectrometry studies using PKC-θ isolated from E. coli
expression system reveal that S685 is an autophosphorylation site
in the turn motif of PKC-θ (Czerwinski et al., 2005). Another
mass spectrometry study using PKC-θ isolated from Jurkat T
cells shows that S685 phosphorylation is induced in Jurkat T cells
upon anti-CD3 stimulation (Mayya et al., 2009). Although S685
phosphorylation of PKC-θ remains to be further veriﬁed using
phospho-speciﬁc antibody, PKC-θ S685A mutant shows signiﬁ-
cantly reduced kinase activity (Czerwinski et al., 2005). The effect
of S685 phosphorylation on the downstream NF-κB activation
has not been reported; but it would be expected to positively
regulate PKC-θ function and T cell activation during TCR sig-
naling. How the phosphorylation at the turn motif affects PKC-θ
catalytic activity is not clear. The electron density maps in crys-
tallization studies of PKC-θ do not deﬁne the turn motif (Xu
et al., 2004); however, the crystallization studies of the kinase
domains of PKC-βII and PKC-ι show that the phosphate on the
turnmotif forms intramolecular ionic contacts to help stabilize the
active conformation of these enzymes (Messerschmidt et al., 2005;
Grodsky et al., 2006). Therefore, the phosphorylation at the turn
motif of PKC-θ may contribute to the regulation of its catalytic
activity.
PHOSPHORYLATION OF PKC-θ AT S695 IN THE HYDROPHOBIC MOTIF
S695 is a constitutive autophosphorylation site in the C-
terminal hydrophobic motif of PKC-θ when isolated from E.
coli/baculovirus/HEK293T expression systems (Liu et al., 2002;
Xu et al., 2004; Czerwinski et al., 2005; Thuille et al., 2005). In
Jurkat T cells, human primary T cells, and mouse primary T cells,
S695 phosphorylation of PKC-θ is induced upon anti-CD3 with
or without CD28 costimulation (Villalba et al., 2002; Freeley et al.,
2005; Lee et al., 2010). A deﬁciency of an essential mTOR complex
2 (mTORC2) subunit RICTOR suppresses PKC-θ phosphoryla-
tion at S696 but not at S676 in mouse primary CD4+ T cells
upon anti-CD3/CD28 stimulation. Thus,mTORC2 regulates S696
phosphorylation of PKC-θ during TCR signaling. S696 phospho-
rylation may contribute to catalytic activity of PKC-θ, which is
important for mTORC2-mediated Th2 differentiation (Lee et al.,
2010). PKC-θ S695A mutant diminishes PKC-θ in vitro kinase
activity, supporting that S695 phosphorylation is required for
optimal PKC-θ kinase activation (Liu et al., 2002; Czerwinski et al.,
2005; Thuille et al., 2005). Crystallographic data of PKC-θ catalytic
domain further support that S695 phosphorylation contributes
to an active conformation of PKC-θ by tightening intramolecular
interaction between the hydrophobicmotif and theN-lobe to align
the αC helix (Xu et al., 2004). Phosphorylation of PKC-βII at the
hydrophobic motif regulates subcellular localization in addition to
catalytic activity of this kinase (Edwards et al., 1999). Membrane-
associated PKC-θ, but not cytosolic PKC-θ, is phosphorylated
at S695, raising the possibility that S695 phosphorylation may
regulate membrane translocation of PKC-θ (Villalba et al., 2002;
Freeley et al., 2005). Two lines of evidence suggest that S695 phos-
phorylation may not be involved in membrane translocation of
PKC-θ: (i) the conventional PKC inhibitor Gö6976 abrogates S695
phosphorylation without affecting membrane translocation of
PKC-θ in Jurkat T cells upon anti-CD3/CD28 stimulation (Freeley
et al., 2005); and (ii) the N-terminal regulatory region but not the
C-terminal kinase domain regulates membrane translocation of
PKC-θ during T cell activation (Bi et al., 2001; Thuille et al., 2005).
Future studies of PKC-θ membrane translocation in T cells using
S695A mutant will provide a conclusive answer. The effect of S695
phosphorylation of PKC-θ on T cell activation varies in different
studies. Catalytically active PKC-θ A148E mutant induces NF-κB
and NF-AT activation in Jurkat T cells upon anti-CD3/CD28 cos-
timulation, which is greatly inhibited by S695Amutation in PKC-θ
A148E mutant (Thuille et al., 2005). In contrast, another study
shows that PKC-θ S695A mutant does not affect NF-κB activation
in the Jurkat T cells upon anti-CD3/CD28 costimulation; paradox-
ically, the kinase activity of PKC-θ S695A mutant is impaired in
the same study (Liu et al., 2002). However, the regulation of PKC-
θ kinase activation by S695 phosphorylation supports that S695
phosphorylation of PKC-θ positively regulates T cell activation
during TCR signaling.
Interdependency of different PKC-θ autophosphorylation sites
Previous studies suggest interdependency of different PKC-θ
autophosphorylation sites. Loss of T538 phosphorylation in PKC-
θ T538A mutant leads to reduced or abolished S676 and S695
phosphorylation in HEK293 cells (Liu et al., 2002). This is likely
the consequence of low catalytic activity of T538A mutant, since
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S676 and S695 are autophosphorylated on the recombinant PKC-θ
protein in vitro (Liu et al., 2002). In addition, treatment with a ser-
ine/threonine phosphatase inhibitor okadaic acid restores the S676
and S695 phosphorylation but not the catalytic activity of PKC-
θ T538A mutant (Liu et al., 2002), supporting an additional or
alternative explanation that mutation of one phosphorylation site
may affect the phosphorylation status at another site by increasing
the susceptibility of this mutant to dephosphorylation by phos-
phatases. On the other hand, PKC-θ S695A mutant results in a
great loss of T538 phosphorylation in HEK293 cells and reduced
in vitro kinase activity (Liu et al., 2000; Czerwinski et al., 2005); this
effect may be attributed to a secondary effect of reduced catalytic
activity of S695A mutant. However, this does not seem to apply to
PKC-θ S676A mutant, which shows reduced catalytic activity but
appears to have intact T538 phosphorylation in HEK293 cells (Liu
et al., 2002; Czerwinski et al., 2005). The unphosphorylated turn
motif in PKC-βII is bound to HSP70, which stabilizes PKC-βII,
allowing re-phosphorylation of this enzyme (Gao and Newton,
2002); this study suggests that PKC-θ S676A may be more sta-
ble and ready for autophosphorylation at T538 due to a loss of
phosphorylation in the turn motif of this mutant. Another possi-
bility is that PKC-θ T538 can be phosphorylated by other kinases.
The relationship of S676 and S695 phosphorylation has not been
reported. Phosphorylations of T219 and T538 in PKC-θ are inde-
pendent of each other, as mutation of either site does not affect
phosphorylation on the other site on baculovirus-expressed PKC-
θ proteins (Thuille et al., 2005). This ﬁnding supports that T219
phosphorylation does not regulate the catalytic activity of PKC-θ
(Thuille et al., 2005); however, it is not clear why T219 autophos-
phorylation is not affected by T538A mutation. One possibility
is that T219 of PKC-θ could also be regulated by other kinases.
While multiple residues of PKC-θ are constitutively autophospho-
rylated in vitro, the relationship of these phosphorylation residues
during TCR signaling has not been studied. Is there sequential
phosphorylation of different sites on PKC-θ upon TCR stim-
ulation? Is there spatial regulation of PKC-θ phosphorylation
during T cell activation? Future studies of these questions may
reveal a novel regulation of PKC-θ activation and function by
phosphorylation.
CONCLUDING REMARKS
In conclusion, phosphorylations play critical roles in regulating
PKC-θ catalytic activity and membrane translocation, both of
which are required for the proper function of PKC-θ in T cell
activation. The regulation of PKC-θ phosphorylation is much
more complex than we initially thought. The individual PKC-θ
phosphorylation sites can be induced by autophosphorylation or
upstream kinases depending on different cell types or cell stimuli.
In TCR signaling, T538 and Y90 are phosphorylated on PKC-θ by
GLK and LCK, respectively. Although phosphorylations of T219,
S676, S685, and S695 are all induced during TCR signaling, the
direct kinases for the phosphorylation of these sites on PKC-θ
remain unclear. T538 phosphorylation is most critical for PKC-θ
catalytic activation, whereas S676, S685, and S695 may be required
for optimal catalytic activation of PKC-θ during TCR signaling.
Phosphorylations of Y90 and T219 regulate PKC-θ membrane
translocation and T-cell activation. PKC-θ is recruited to different
locations in effector T cells and regulatory T cells and performs
opposite functions in these cells (Zanin-Zhorov et al., 2010). For
example, PKC-θ localizes to the immunological synapse and posi-
tively regulates cellular activation in effector T cells, while PKC-θ is
sequestered away from the immunological synapse in stimulated
regulatory T cells and negatively regulates cell function (Zanin-
Zhorov et al., 2010). On a similar note, a substantial amount of
PKC-θ is constitutively located in the nucleus of T cells, where it
regulates gene expression (Sutcliffe et al., 2011). It might therefore
be appropriate to speculate that different phosphorylation sites
(e.g., Y90, T219, or other sites) of PKC-θ may inﬂuence its distri-
bution to different subcellular locations. The model of regulation
of PKC-θ phosphorylation in TCR signaling is shown (Figure 3).
FIGURE 3 |The model of regulation of PKC-θ phosphorylation during
TCR signaling. Ligation of TCR induces the activation of tyrosine kinase
LCK. LCK activates ZAP-70, which in turn induces tyrosine phosphorylation
of the adaptor SLP-76. SLP-76 directly interacts with and activates PLCγ1
and GLK. PLCγ1 cleaves a phospholipid, generating the second messenger
diacylglycerol. The binding of diacylglycerol with PKC-θ induces the
conformational change of PKC-θ; T538 of PKC-θ is then phosphorylated by
GLK, leading to catalytic activation of PKC-θ. The CD28 costimulatory
activates PDK-1, which facilitates PKC-θT538 phosphorylation possibly via
activating GLK. AMPK is also implicated in PKC-θT538 phosphorylation in
T cells. LCK directly interacts with and phosphorylates PKC-θ at Y90. The
phosphorylation of Y90 and another residue (T219) induces membrane
translocation of PKC-θ. S676, S685, and S695 residues are also
phosphorylated on PKC-θ uponTCR stimulation. mTORC2 activity is
required for PKC-θ S695 phosphorylation in T cells. Catalytic activation and
membrane translocation of PKC-θ lead to the activation of transcription
factors NF-κB, NF-AT, and AP-1, and to subsequent T cell activation.
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How such a complex regulation of PKC-θ phosphorylation is
integrated with TCR/CD28 signaling is the key for the future
understanding of PKC-θ function and T cell activation. Speciﬁ-
cally, what kinases or phosphatases regulate the important PKC-θ
phosphorylation sites in T-cell signaling? Does the phosphoryla-
tion of PKC-θ at different residues occur in a sequential and spatial
manner during T cell signaling? How does PKC-θ phosphoryla-
tion at a speciﬁc site regulate its catalytic activity and membrane
translocation? Future studies of the regulatory mechanisms of
PKC-θ phosphorylation are important not only for the under-
standing of the underlying mechanism of PKC-θ-mediated cell
activation, but also for the design of novel therapeutic targets for
PKC-θ-mediated inﬂammatory diseases.
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